Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
20 pending office actions • 9 art units • 14 examiners • 0 of 20 (0%) have an AI response strategy ready • 33 patents granted in the last 365 days
GEN-PROBE Incorporated has 21 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 15 examiners and 9 art units, showing a broad examination footprint with multiple matters assigned within some art units.
CHUNDURU, SURYAPRABHA is the busiest examiner, with 3 pending matters. That assignment creates a useful focal point for reviewing recurring objections, interview opportunities, and response approaches, although most of the portfolio remains distributed among other examiners. The difference between examiner and art-unit coverage also suggests that art-unit-level coordination may reveal common prosecution themes that are not visible from examiner assignments alone.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (5%) |
| §103 only | 9 (45%) |
| §112 only | 1 (5%) |
| Double-patenting only | 2 (10%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 5 (25%) |
| No statute on record | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRCHA, MATTHEW D | 3 | 64.3% | +35.5% |
| HARP, WILLIAM RAY | 2 | 79.1% | +10.8% |
| CHUNDURU, SURYAPRABHA | 2 | 53.3% | +17.2% |
| THOMPSON, CURTIS A | 2 | 61.2% | +51.6% |
| GIAMMONA, FRANCESCA FILIPPA | 2 | 37.3% | +58.8% |
| KOVACH, KARA NICOLE | 1 | 85.7% | +100.0% |
| GZYBOWSKI, MICHAEL STANLEY | 1 | 67.6% | +52.2% |
| JONES, CHRISTINE MICHELLE | 1 | 0.0% | +0.0% |
| HILL, MYRON G | 1 | 66.1% | +20.7% |
| PULLIAM, JOSEPH CONSTANTINE | 1 | 38.5% | +33.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17259128 | METHODS AND SYSTEMS FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS | DHARITHREESAN, NIDHI | 34d |
| 18659881 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | — |
| 18659963 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | — |
| 18564575 | ENZYME FORMULATIONS AND REACTION MIXTURES FOR NUCLEIC ACID AMPLIFICATION | JONES, CHRISTINE MICHELLE | — |
| 18558346 | COMPOSITIONS AND METHODS FOR DETECTING HUMAN ADENOVIRUS NUCLEIC ACID | HILL, MYRON G | — |
| 18379892 | APPARATUS FOR APPLYING THERMAL ENERGY TO A RECEPTACLE AND DETECTING AN EMISSION SIGNAL FROM THE RECEPTACLE | KRCHA, MATTHEW D | — |
| 17382568 | DETECTION OF DRUG-RESISTANT MYCOPLASMA GENITALIUM | GIAMMONA, FRANCESCA FILIPPA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19196900 | RECEPTACLE TRANSPORT SYSTEM FOR AN ANALYTICAL SYSTEM | HARP, WILLIAM RAY | — |
| 18990228 | RECEPTACLE TRANSPORT SYSTEM FOR AN ANALYTICAL SYSTEM | HARP, WILLIAM RAY | — |
| 18939319 | TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING | CHUNDURU, SURYAPRABHA | — |
| 18771684 | BLOOD CELL LYSIS REAGENT | KOVACH, KARA NICOLE | — |
| 18659881 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | — |
| 18659963 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | — |
| 18694253 | TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING | CHUNDURU, SURYAPRABHA | — |
| 18292281 | AUTOMATED SYSTEMS AND METHODS FOR LOADING SOLID REAGENT PELLETS INTO WELLS OF A CARTRIDGE | GZYBOWSKI, MICHAEL STANLEY | — |
| Art Unit | Apps |
|---|---|
| 1681 | 6 |
| 1798 | 3 |
| 1796 | 3 |
| 3653 | 2 |
| 1683 | 2 |
| 1682 | 1 |
| 1671 | 1 |
| 1687 | 1 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19196900 | RECEPTACLE TRANSPORT SYSTEM FOR AN ANALYTICAL SYSTEM | HARP, WILLIAM RAY | 3653 | DP | Non-Final OA | — | Pending | May 02, 2025 |
| 18990228 | RECEPTACLE TRANSPORT SYSTEM FOR AN ANALYTICAL SYSTEM | HARP, WILLIAM RAY | 3653 | §102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18939319 | TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING | CHUNDURU, SURYAPRABHA | 1681 | §103 | Non-Final OA | — | Pending | Nov 06, 2024 |
| 18771684 | BLOOD CELL LYSIS REAGENT | KOVACH, KARA NICOLE | 1681 | Other | Non-Final OA | — | Pending | Jul 12, 2024 |
| 18659881 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | 1798 | §103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18659963 | FLUID CONTAINER MANAGEMENT SYSTEM | THOMPSON, CURTIS A | 1798 | §102§103§112 | Non-Final OA | — | Pending | May 09, 2024 |
| 18694253 | TEMPERATURE-SELECTABLE FRET CASSETTE SIGNALING | CHUNDURU, SURYAPRABHA | 1681 | §103 | Non-Final OA | — | Pending | Mar 21, 2024 |
| 18292281 | AUTOMATED SYSTEMS AND METHODS FOR LOADING SOLID REAGENT PELLETS INTO WELLS OF A CARTRIDGE | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18564575 | ENZYME FORMULATIONS AND REACTION MIXTURES FOR NUCLEIC ACID AMPLIFICATION | JONES, CHRISTINE MICHELLE | 1682 | §103 | Final Rejection | — | Pending | Nov 27, 2023 |
| 18386976 | APPARATUS FOR APPLYING THERMAL ENERGY TO A RECEPTACLE AND DETECTING AN EMISSION SIGNAL FROM THE RECEPTACLE | KRCHA, MATTHEW D | 1796 | §103 | Non-Final OA | — | Pending | Nov 03, 2023 |
| 18558346 | COMPOSITIONS AND METHODS FOR DETECTING HUMAN ADENOVIRUS NUCLEIC ACID | HILL, MYRON G | 1671 | §103§112 | Non-Final OA | — | Pending | Oct 31, 2023 |
| 18379892 | APPARATUS FOR APPLYING THERMAL ENERGY TO A RECEPTACLE AND DETECTING AN EMISSION SIGNAL FROM THE RECEPTACLE | KRCHA, MATTHEW D | 1796 | §103§112 | Non-Final OA | — | Pending | Oct 13, 2023 |
| 18465134 | APPARATUS FOR APPLYING THERMAL ENERGY TO A RECEPTACLE AND DETECTING AN EMISSION SIGNAL FROM THE RECEPTACLE | KRCHA, MATTHEW D | 1796 | DP | Final Rejection | — | Pending | Sep 11, 2023 |
| 18236812 | Calibration Method, Apparatus and Computer Program Product | PULLIAM, JOSEPH CONSTANTINE | 1687 | §103 | Non-Final OA | — | Pending | Aug 22, 2023 |
| 18361797 | SYSTEM FOR PERFORMING NUCLEIC ACID AMPLIFICATION ASSAYS | SCHLOOP, ALLISON ELIZABETH | 1683 | §103Other | Final Rejection | 27d | Pending | Jul 28, 2023 |
| 18361763 | METHOD OF DETECTING MULTIPLE FORMS OF AN ANALYTE | YU, TIAN NMN | 1681 | §112 | Final Rejection | — | Pending | Jul 28, 2023 |
| 17541117 | CLOSED NUCLEIC ACID STRUCTURES | HOPPE, EMMA RUTH | 1683 | §103Other | Non-Final OA | 131d overdue | Pending | Dec 02, 2021 |
| 17441526 | Compositions and Methods for Detecting Group A Streptococcus | GIAMMONA, FRANCESCA FILIPPA | 1681 | §103 | Non-Final OA | — | Pending | Sep 21, 2021 |
| 17382568 | DETECTION OF DRUG-RESISTANT MYCOPLASMA GENITALIUM | GIAMMONA, FRANCESCA FILIPPA | 1681 | §102§103§112 | Non-Final OA | — | Pending | Jul 22, 2021 |
| 17259128 | METHODS AND SYSTEMS FOR DETECTING AND QUANTIFYING NUCLEIC ACIDS | DHARITHREESAN, NIDHI | 1686 | §101§103 | Final Rejection | 34d | Pending | Jan 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGEN-PROBE Incorporated has 20 pending office actions as of October 2026, spread across 9 art units and 14 examiners.
Matthew D Krcha has the most, with 3 of GEN-PROBE Incorporated's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
